← Back to headlines
Biomea Fusion Stock Surges on Diabetes Trial Enrollment Completion
Biomea Fusion's stock surged following the announcement of the completion of enrollment for its diabetes trial.
24 Aug, 14:54 — 24 Aug, 14:54
Sources
Showing 1 of 1 sources
